Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 26,547 | 25,191 | 22,986 | 15,633 | 18,895 |
| Cost of Goods | 39 | N/A | N/A | N/A | N/A |
| Gross Profit | 26,508 | 25,191 | 22,986 | 15,633 | 18,895 |
| Operating Expenses | 52,902 | 50,183 | 55,050 | 52,193 | 57,337 |
| Operating Income | -26,355 | -24,992 | -32,064 | -36,560 | -38,442 |
| Interest Expense | 2,219 | 2,127 | 2,133 | 2,060 | 1,956 |
| Other Income | -318 | 687 | -786 | -387 | -721 |
| Pre-tax Income | -28,892 | -26,432 | -34,983 | -39,007 | -41,119 |
| Income Tax | 165 | 364 | 184 | -93 | 114 |
| Net Income Continuous | -29,057 | -26,796 | -35,167 | -38,914 | -41,233 |
| Net Income | $-29,057 | $-26,796 | $-35,167 | $-38,914 | $-41,233 |
| EPS Basic Total Ops | -0.85 | -0.78 | -1.03 | -1.14 | -1.22 |
| EPS Basic Continuous Ops | -0.85 | -0.78 | -1.03 | -1.14 | -1.22 |
| EPS Diluted Total Ops | -0.85 | -0.78 | -1.03 | -1.14 | -1.22 |
| EPS Diluted Continuous Ops | -0.85 | -0.78 | -1.03 | -1.14 | -1.22 |
| EBITDA(a) | $-25,455 | $-23,826 | $-30,704 | $-35,161 | $-36,890 |